Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation

No clear dosing guidelines exist for cyclophosphamide (Cy) dose adjustments in obese patients treated with high-dose chemoradiotherapy followed by autologous hematopoietic cell transplantation (HCT). We prospectively compared the outcomes of high-dose Cy/total body irradiation (TBI) conditioning in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biol Blood Marrow Transplant
Huvudupphovsmän: Bachanova, Veronika, Rogosheske, John, Shanley, Ryan, Burns, Linda J., Smith, Sara M., Weisdorf, Daniel J., Brunstein, Claudio G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4753782/
https://ncbi.nlm.nih.gov/pubmed/26497907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.10.012
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk